Dr. Patrick Soon-Shiong, Chairman and CEO of ImmunityBio, explains why T-cell immunity could be an important metric when evaluating experimental COVID-19 vaccines. camera phoneCoronaviruscoronavirus immunitycovidCOVID-19COVID19freeGenerateimmune systemIMMUNITYLastingModern39ssharinguploadVaccinevideovideo phoneVITAMINvlogYouTube
